Clinical Trials

Can Yoga Modestly Improve Cardiometabolic Health in Obesity?
Research & Development Can Yoga Modestly Improve Cardiometabolic Health in Obesity?

For adults carrying excess weight who are urged to “move more” yet face pain, low fitness, or limited mobility, the search for an exercise approach that is safe, approachable, and still effective can feel like an unsolved puzzle with too many missing pieces and too few realistic options. That

Obesity Leaves Years-Long Epigenetic Memory in T Cells
Research & Development Obesity Leaves Years-Long Epigenetic Memory in T Cells

Long after scales celebrate a hard-won weight loss, the immune system can keep score in subtler ways, storing traces of past obesity inside helper T cells as molecular marks that linger and continue to shape health in the background. This emerging insight reframes obesity as more than excess fat;

FDA OKs J&J’s Icotyde, First Oral IL-23 Psoriasis Drug
Research & Development FDA OKs J&J’s Icotyde, First Oral IL-23 Psoriasis Drug

Clinic days often hinge on one question patients ask with a mix of hope and hesitation: is there a pill that can match the clearing power of injections without the needles, the storage hassles, or the crowded appointment calendar. That answer just shifted as the FDA cleared Johnson & Johnson’s

Do Parallel Human–AI Workflows Improve Care Decisions?
Research & Development Do Parallel Human–AI Workflows Improve Care Decisions?

Ivan Kairatov brings a biopharma lens to clinician-AI collaboration, blending R&D rigor with practical know‑how from tech-enabled trials. In recent studies, chatbots not only matched but sometimes outperformed clinicians on management reasoning tasks, especially when teams used deliberate workflows

Can Engineered BEVs Be the Next Weapon Against AMR?
Research & Development Can Engineered BEVs Be the Next Weapon Against AMR?

Relentless rises in drug-resistant infections have turned routine care into a negotiation with risk that standard antibiotics too often lose, and the search for smarter countermeasures has shifted to tools built by biology itself. Bacterial extracellular vesicles (BEVs) sit at that inflection

Can Hyperbaric Oxygen Help or Hinder Glioblastoma Therapy?
Tech & Innovation Can Hyperbaric Oxygen Help or Hinder Glioblastoma Therapy?

Oxygen can sharpen the sword or feed the fire in glioblastoma therapy, and hyperbaric dosing, timing, and biology together decide which edge cuts and whether treatment harms or helps. This research summary examines how hyperbaric oxygen therapy (HBOT) might both strengthen and undermine standard

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later